{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T22:00:29Z","timestamp":1775080829224,"version":"3.50.1"},"reference-count":41,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2004,6,1]],"date-time":"2004-06-01T00:00:00Z","timestamp":1086048000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2004,6]]},"DOI":"10.1002\/jps.20080","type":"journal-article","created":{"date-parts":[[2004,3,26]],"date-time":"2004-03-26T20:01:12Z","timestamp":1080331272000},"page":"1382-1389","source":"Crossref","is-referenced-by-count":25,"title":["Assessing the antifungal activity and toxicity profile of amphotericin B lipid complex (ABLC; Abelcet\u00ae) in combination with caspofungin in experimental systemic aspergillosis"],"prefix":"10.1016","volume":"93","author":[{"given":"Olena","family":"Sivak","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karen","family":"Bartlett","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Verica","family":"Risovic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eugene","family":"Choo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fawziah","family":"Marra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"suffix":"Jr.","given":"D.","family":"Scotty Batty","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kishor M.","family":"Wasan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1002\/jps.20080_bb0010","doi-asserted-by":"crossref","first-page":"2201","DOI":"10.1128\/AAC.41.10.2201","article-title":"Pharmacokinetic profile of ABELCET (amphotericin B lipid complex injection): Combined experience from phase I and phase II studies","volume":"41","author":"Adedoyin","year":"1997","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1002\/jps.20080_bb0015","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1002\/cncr.11115","article-title":"Refractory Aspergillus pneumonia in patients with acute leukemia: Successful therapy with combination caspofungin and liposomal amphotericin B","volume":"97","author":"Aliff","year":"2003","journal-title":"Cancer"},{"issue":"1","key":"10.1002\/jps.20080_bb0020","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1128\/AAC.46.1.245-247.2002","article-title":"In vitro synergy of caspofungin and amphotericin B against Aspergillus and Fusarium spp","volume":"46","author":"Arikan","year":"2002","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1002\/jps.20080_bb0025","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/BF00273522","article-title":"Analysis of the effect of liposomal encapsulation on the vesicant properties, acute and cardiac toxicities, and antitumor efficacy of doxorubicin","volume":"23","author":"Balazsovits","year":"1989","journal-title":"Cancer Chemother Pharmacol"},{"key":"10.1002\/jps.20080_bb0030","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1128\/AAC.41.5.886","article-title":"Behaviour of amphotericin B lipid complex in plasma in vitro and in the circulation of rats","volume":"41","author":"Bhamra","year":"1997","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1002\/jps.20080_bb0035","series-title":"Statistical estimates and transformed beta variables","first-page":"1","author":"Blom","year":"1958"},{"key":"10.1002\/jps.20080_bb0040","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/0002-9343(86)90510-3","article-title":"Infection in cancer patients: A continuing association","volume":"81","author":"Bodey","year":"1986","journal-title":"Am J Med"},{"key":"10.1002\/jps.20080_bb0045","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1002\/jps.2600780409","article-title":"Pharmacokinetics and toxicity of continuous infusion of amphotericin B in cancer patients","volume":"78","author":"Chabot","year":"1989","journal-title":"J Pharm Sci"},{"key":"10.1002\/jps.20080_bb0050","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1097\/01.inf.0000073060.20277.29","article-title":"Combination therapy with caspofungin and liposomal amphotericin B for invasive aspergillosis","volume":"22","author":"Elanjikal","year":"2003","journal-title":"Pediatr Infect Dis J"},{"issue":"2","key":"10.1002\/jps.20080_bb0055","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1128\/AAC.41.2.331","article-title":"Pneumocandin L\u2010743,872 enhances the activities of amphotericin B and fluconazole against Cryptococcus neoformans in vitro","volume":"41","author":"Franzot","year":"1997","journal-title":"Antimicrob Agents Chemother"},{"issue":"4","key":"10.1002\/jps.20080_bb0060","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1097\/00001622-200307000-00001","article-title":"New antifungal drugs and new clinical trials: Interpreting results may be difficult","volume":"15","author":"Girmenia","year":"2003","journal-title":"Curr Opin Oncol"},{"issue":"2\u20133","key":"10.1002\/jps.20080_bb0065","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S0169-409X(01)00104-1","article-title":"Amphotericin B colloidal dispersion: An improved antifungal therapy","volume":"47","author":"Guo","year":"2001","journal-title":"Adv Drug Deliv Rev"},{"issue":"11","key":"10.1002\/jps.20080_bb0070","doi-asserted-by":"crossref","first-page":"2339","DOI":"10.1128\/AAC.41.11.2339","article-title":"Preliminary animal pharmacokinetics of the parenteral antifungal agent MK\u20100991 (L\u2010743,872)","volume":"41","author":"Hajdu","year":"1997","journal-title":"Antimicrob Agents Chemother"},{"issue":"7","key":"10.1002\/jps.20080_bb0075","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/S0002-9343(01)00928-7","article-title":"The epidemiology of nephrotoxicity associated with conventional amphotericin B therapy","volume":"111","author":"Harbarth","year":"2001","journal-title":"Am J Med"},{"key":"10.1002\/jps.20080_bb0080","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1002\/cncr.11479","article-title":"Efficacy and toxicity of caspofungin in combination with liposomal amphotericin B as primary or salvage treatment of invasive aspergillosis in patients with hematologic malignancies","volume":"98","author":"Kontoyiannis","year":"2003","journal-title":"Cancer"},{"key":"10.1002\/jps.20080_bb0085","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1093\/infdis\/147.5.939","article-title":"Treatment and prophylaxis of disseminated infection due to Candida albicans in mice with liposomal\u2010encapsulated amphotericin B","volume":"147","author":"Lopez\u2010Berestein","year":"1983","journal-title":"J Infect Dis"},{"key":"10.1002\/jps.20080_bb0090","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1089\/cdd.1984.1.199","article-title":"Altered tissue distribution of amphotericin B by liposomal encapsulation: Comparison of normal mice to mice infected with Candida albicans","volume":"1","author":"Lopez\u2010Berestein","year":"1984","journal-title":"Cancer Drug Deliv"},{"issue":"1","key":"10.1002\/jps.20080_bb0095","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1093\/ajhp\/59.1.80","article-title":"Combination therapy with caspofungin and amphotericin B lipid complex","volume":"59","author":"Lum","year":"2002","journal-title":"Am J Health Syst Pharm"},{"issue":"5\u20136","key":"10.1002\/jps.20080_bb0100","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1046\/j.1439-0507.2002.00741.x","article-title":"Epidemiology, treatment and outcome of candidemia: A five\u2010year review at three Canadian hospitals","volume":"45","author":"MacPhail","year":"2002","journal-title":"Mycoses"},{"issue":"2","key":"10.1002\/jps.20080_bb0105","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1517\/14656566.3.2.91","article-title":"Antifungal use in HIV infection","volume":"3","author":"Marty","year":"2002","journal-title":"Exp Opin Pharmacother"},{"key":"10.1002\/jps.20080_bb0110","doi-asserted-by":"crossref","first-page":"S154","DOI":"10.1093\/clinids\/14.Supplement_1.S154","article-title":"Current role of therapy with amphotericin B","volume":"14","author":"Meyer","year":"1992","journal-title":"Clin Infect Dis"},{"issue":"1","key":"10.1002\/jps.20080_bb0115","first-page":"67","article-title":"Development of liposomal polyene antibiotics: An historical perspective","volume":"6","author":"Ng","year":"2003","journal-title":"J Pharm Pharm Sci"},{"issue":"4","key":"10.1002\/jps.20080_bb0120","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/S0891-5520(02)00034-X","article-title":"Deeply invasive candidiasis","volume":"16","author":"Ostrosky\u2010Zeichner","year":"2002","journal-title":"Infect Dis Clin North Am"},{"key":"10.1002\/jps.20080_bb0125","first-page":"6269","article-title":"Toxicity and antitumor activity of cis\u2010bis\u2010cyclopentenecarboxylato\u20101,2\u2010diaminocyclohexane platinum (II) encapsulated in multilamellar vesicles","volume":"46","author":"Perez\u2010Soler","year":"1986","journal-title":"Cancer Res"},{"issue":"1","key":"10.1002\/jps.20080_bb0130","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1128\/AAC.46.1.12-23.2002","article-title":"Antifungal efficacy of caspofungin (MK\u20100991) in experimental pulmonary aspergillosis in persistently neutropenic rabbits: Pharmacokinetics, drug disposition, and relationship to galactomannan antigenemia","volume":"46","author":"Petraitiene","year":"2002","journal-title":"Antimicrob Agents Chemother"},{"issue":"9","key":"10.1002\/jps.20080_bb0135","first-page":"1333","article-title":"ORs closed after Aspergillus discovered at Royal Vic","volume":"164","author":"Pinker","year":"2001","journal-title":"CMAJ"},{"key":"10.1002\/jps.20080_bb0140","first-page":"59","article-title":"Antifungal therapy\u2010state of the art at the beginning of the 21st century","author":"Polak","year":"2003","journal-title":"Prog Drug Res"},{"issue":"9","key":"10.1002\/jps.20080_bb0145","doi-asserted-by":"crossref","first-page":"3096","DOI":"10.1128\/AAC.46.9.3096-3100.2002","article-title":"Effect of the echinocandin caspofungin on expression of Candida albicans secretory aspartyl proteinases and phospholipase in vitro","volume":"46","author":"Ripeau","year":"2002","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1002\/jps.20080_bb0150","first-page":"S154","article-title":"Prevalence of HIV infection in provincial prisons in British Columbia","volume":"151","author":"Rothon","year":"1994","journal-title":"Can J Med Assoc"},{"issue":"4","key":"10.1002\/jps.20080_bb0155","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1016\/S0891-5520(02)00043-0","article-title":"Fungal infections in nontransplant patients with hematologic malignancies","volume":"16","author":"Segal","year":"2002","journal-title":"Infect Dis Clin North Am"},{"issue":"3","key":"10.1002\/jps.20080_bb0160","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1128\/JCM.39.3.949-953.2001","article-title":"Prevalence and antifungal susceptibility of 442 Candida isolates from blood and other normally sterile sites: Results of a 2\u2010year (1996 to 1998) multicenter surveillance study in Quebec, Canada","volume":"39","author":"St\u2010Germain","year":"2001","journal-title":"J Clin Microbiol"},{"issue":"4","key":"10.1002\/jps.20080_bb0165","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1128\/AAC.42.4.767","article-title":"In vitro and in vivo antifungal activity of amphotericin B lipid complex: Are phospholipases important?","volume":"42","author":"Swenson","year":"1998","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1002\/jps.20080_bb0170","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1164\/arrd.1982.125.5.610","article-title":"Amphotericin B in liposomes: A novel therapy for histoplasmosis","volume":"125","author":"Taylor","year":"1982","journal-title":"Am Rev Respir Dis"},{"key":"10.1002\/jps.20080_bb0175","first-page":"1147","article-title":"Tissue distribution and in vivo immunosuppressive activity of liposomal cyclosporine","volume":"19","author":"Vadiei","year":"1991","journal-title":"Drug Metab Disp"},{"key":"10.1002\/jps.20080_bb0180","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1007\/s10096-002-0781-6","article-title":"Combined antifungal treatment of visceral mucormycosis with caspofungin and liposomal amphotericin B","volume":"21","author":"Voitl","year":"2002","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1002\/jps.20080_bb0185","first-page":"467","article-title":"Chronic silastic central venous catherization for reduction, maintenance, and support of persistent granulocytopenia in rabbits","volume":"38","author":"Walsh","year":"1988","journal-title":"Lab Anim Sci"},{"key":"10.1002\/jps.20080_bb0190","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1093\/clinids\/24.1.78","article-title":"Enhanced amphotericin B nephrotoxicity in intensive care patients with elevated levels of low\u2010density lipoprotein cholesterol","volume":"24","author":"Wasan","year":"1997","journal-title":"Clin Infect Dis"},{"key":"10.1002\/jps.20080_bb0195","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1093\/infdis\/161.3.562","article-title":"Pharmacokinetics, tissue distribution, and toxicity of free and liposomal amphotericin B in diabetic rats","volume":"161","author":"Wasan","year":"1990","journal-title":"J Infect Dis"},{"key":"10.1002\/jps.20080_bb0200","doi-asserted-by":"crossref","first-page":"3146","DOI":"10.1128\/AAC.42.12.3146","article-title":"Pharmacokinetics, distribution in serum lipoprotein and tissues, and renal toxicities of amphotericin B and amphotericin B lipid complex in a hypercholesterolemic rabbit model: Single dose studies","volume":"42","author":"Wasan","year":"1998","journal-title":"Antimicrob Agents Chemother"},{"issue":"4","key":"10.1002\/jps.20080_bb0205","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1097\/00043426-200304000-00004","article-title":"Prolonged survival after invasive aspergillosis: A single\u2010institution review of 11 cases","volume":"25","author":"Wright","year":"2003","journal-title":"J Pediatr Hematol Oncol"},{"issue":"4","key":"10.1002\/jps.20080_bb0210","first-page":"493","article-title":"Candidemia at selected Canadian sites: Results from the Fungal Disease Registry, 1992\u20131994. Fungal Disease Registry of the Canadian Infectious Disease Society","volume":"160","author":"Yamamura","year":"1999","journal-title":"CMAJ"}],"container-title":["Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354916315179?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354916315179?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,3,31]],"date-time":"2020-03-31T20:21:50Z","timestamp":1585686110000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022354916315179"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,6]]},"references-count":41,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2004,6]]}},"alternative-id":["S0022354916315179"],"URL":"https:\/\/doi.org\/10.1002\/jps.20080","relation":{},"ISSN":["0022-3549"],"issn-type":[{"value":"0022-3549","type":"print"}],"subject":[],"published":{"date-parts":[[2004,6]]}}}